Abstract
The upper respiratory tract (URT) virome is crucial in respiratory health and response to pathogens. While common respiratory viruses are well-studied, the presence and potential impact of giant DNA viruses, such as Mimiviridae, in the human URT remain underexplored. This study employed a whole genome metagenomics approach to profile the URT virome of 48 SARS-CoV-2-positive patients from central India. Mimiviridae reads were detected in two elderly male patients with severe acute respiratory infection (SARI) or influenza-like illness (ILI), contributing to 24% and 44% of the total virome in their samples. The dominant species were Acanthamoeba polyphaga mimivirus and Moumouvirus. Although Mimiviridae are not traditionally associated with human respiratory infections, their presence in SARS-CoV-2 patients raises questions about their potential role in co-infections and disease severity, particularly in individuals with ongoing respiratory infections. These findings underscore the need to investigate further giant viruses’ clinical significance, transmission, and pathogenicity in humans. Future research should focus on their epidemiology and the development of improved diagnostic tools to assess their contribution to human health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors are thankful to CSIR-NEERI for providing funds under project OLP-57 (March 2023 - April 2024) for conducting this study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Ethics Committee for Research on Human Subjects (IEC) of CSIR-NEERI, Nagpur-20, India
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The materials and methods section is revised as under "Tomar et. al. 2024" is changed to "Tomar and Khairnar 2024"
